HPR2 Baseline Characteristics of Patients Applying for Reimbursment of Liraglutide (Saxenda®) for Weight Management Under a Managed Access Protocol in Ireland
Abstract
Authors
C. Gorry M. Daly S. Doran K. Finnigan S. Clarke M. Barry